Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?
394 Followers
Spyre Therapeutics (SYRE) Ownership Overview
19.89% Insiders
8.14% Mutual Funds
1.92% Other Institutional Investors
70.06% Public Companies and
Individual Investors
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail and individual investors. Approximately 10.06% of the company’s stock is owned by Institutional Investors, 19.89% is owned by Insiders and 70.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $430206 | |
| Dec 31, 2023 | Sold | $16611331 | |
| Dec 31, 2023 | Bought | $56095732 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,410,106 | Institution | 9.43% | 121,331,571 | |
| 2,606,679 | Institution | 7.21% | 92,745,639 | |
| 1,320,839 | Institution | 3.65% | 46,995,452 | |
| 771,902 | Institution | 2.14% | 27,464,273 | |
| 671,695 | Institution | 1.86% | 23,898,908 | |
| 470,457 | Institution | 1.30% | 16,738,860 | |
| 378,421 | Institution | 1.05% | 13,464,219 | |
| 353,495 | Institution | 0.98% | 12,577,352 | |
| 220,000 | Institution | 0.61% | 7,827,600 | |
| 152,226 | Institution | 0.42% | 5,416,201 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,320,839 | Institution | 3.65% | 46,995,452 | |
| 671,695 | Institution | 1.86% | 23,898,908 | |
| 353,495 | Institution | 0.98% | 12,577,352 | |
| 220,000 | Institution | 0.61% | 7,827,600 | |
| 150,000 | Institution | 0.41% | 5,337,000 | |
| 90,017 | Institution | 0.25% | 3,202,805 | |
| 62,004 | Institution | 0.17% | 2,206,102 | |
| 34,242 | Institution | 0.09% | 1,218,330 | |
| 33,281 | Institution | 0.09% | 1,184,138 | |
| 5,693 | Institution | 0.02% | 202,557 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 470,457 | Institution | 1.30% | 17,844,434 | |
| 90,531 | Institution | 0.25% | 3,221,093 | |
| 61,695 | Institution | 0.17% | 2,195,108 | |
| 35,883 | Institution | 0.10% | 1,276,717 | |
| 9,974 | Institution | 0.03% | 342,208 | |
| 5,838 | Institution | 0.02% | 207,716 | |
| 4,329 | Institution | 0.01% | 148,528 | |
| 2,500 | Institution | <0.01% | 85,775 |
FAQ
Who Owns Spyre Therapeutics (SYRE)?
According to the latest TipRanks data, approximately 1.92% of the company's stock is held by institutional investors, 19.89% is held by insiders, and 70.06% is held by retail investors.
What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.92% of Spyre Therapeutics (SYRE) stock is held by institutional investors.
What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.06% of Spyre Therapeutics (SYRE) stock is held by retail investors.
Who owns the most shares of Spyre Therapeutics (SYRE)?
Felix Baker owns the most shares of Spyre Therapeutics (SYRE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.